This inventor holds 1 USPTO granted patent. Top assignee: Kyowa Hakko Kirin Co., Limited. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Innovator in Antibody Research: Shinobu Kawamoto
Introduction
Shinobu Kawamoto, an accomplished inventor based in Machida, Japan, has made significant contributions to the field of biotechnology, particularly in the development of therapeutic agents. His innovative work has resulted in a patent that enhances diagnostic and therapeutic possibilities for diseases associated with specific polypeptides.
Latest Patents
Kawamoto holds a patent for an anti-claudin-4 antibody. This invention aims to provide a monoclonal antibody useful for diagnosing or treating diseases related to the polypeptides encoded by the Claudin-4 (CLDN4) and Claudin-3 (CLDN3) genes. The patent outlines a monoclonal antibody or an antibody fragment that specifically recognizes the three-dimensional structure of the extracellular region of CLDN4, as well as the corresponding regions for CLDN3. The invention also includes details about the hybridoma producing the antibody, the DNA encoding the antibody, and the processes for producing these antibodies for use in therapeutic and diagnostic contexts.
Career Highlights
Shinobu Kawamoto works with Kyowa Hakko Kirin Co., Limited, a respected company in the biopharmaceutical industry. His research and development efforts at the company focus on innovative protein-based therapeutics. Kawamoto’s dedication and skill in monoclonal antibody research are evident in his successful patent acquisition.
Collaborations
Collaborating with esteemed colleagues such as So Ohta and Hiroshi Ando, Kawamoto has contributed to advancing knowledge in antibody development. These partnerships have fostered an environment of innovation and scientific inquiry, enhancing the potential applications of their collective research.
Conclusion
Shinobu Kawamoto exemplifies the spirit of innovation within the field of biotechnology. His patented work on the anti-claudin-4 antibody not only represents a significant leap forward in the treatment of related diseases but also highlights the importance of collaboration in scientific research. Through his contributions, Kawamoto continues to impact the medical community positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile